Zobrazeno 1 - 10
of 440
pro vyhledávání: '"Gautam H"'
Autor:
De, Brian *, Andres, Grant, Bates, Christine, Staren, Edgar, Kutscher, Eric, Brooks, Donald J., Thaker, Gautam H., Buscema, Joseph, Gin, Robert, Thaker, Nikhil
Publikováno v:
In International Journal of Radiation Oncology, Biology, Physics 1 July 2023 116(3):491-499
Autor:
Thaker, Nikhil G., Meghani, Rehman, Wilson, Cassandra, Garey, Jody, Nelson, Philip, Thaker, Gautam H., Shah, Chirag, Orio, Peter, Yashar, Catheryn M., Kavadi, Vivek
Publikováno v:
In Brachytherapy January-February 2022 21(1):55-62
Autor:
Gautam, H. R., Bhardwaj, M. L.
Publikováno v:
Current Science, 2020 Mar . 118(6), 857-857.
Externí odkaz:
https://www.jstor.org/stable/27226374
Publikováno v:
In Materials Today: Proceedings 2021 43 Part 2:916-920
Autor:
Brian De, Grant Andres, Christine Bates, Edgar Staren, Eric Kutscher, Donald J. Brooks, Gautam H. Thaker, Joseph Buscema, Robert Gin, Nikhil Thaker
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:491-499
Publikováno v:
International Journal of Economic Plants. Feb2022, Vol. 9 Issue 1, p011-017. 7p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chirag Shah, Rehman Meghani, Nikhil G. Thaker, Peter F. Orio, Jody Garey, Catheryn M. Yashar, Philip Nelson, Cassandra Wilson, Gautam H. Thaker, Vivek Kavadi
Publikováno v:
Brachytherapy. 21:55-62
PURPOSE The Radiation Oncology Alternative Payment Model (RO Model) will test prospective radiotherapy episode-based payments for 16 common disease sites. We created an automated analytics platform to calculate the impact of the RO Model vs historica
Autor:
Anjanjyoti Rajkonwar, Upam Kumar Sharma, Sima Sonowal, Arpita Nath, Hiranya Saikia, Gautam Hazarika
Publikováno v:
Asian Journal of Medical Sciences, Vol 15, Iss 6, Pp 101-106 (2024)
Background: Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by excessive growth of myeloid cells and their progenitors. The incidence of CML is approximately 1–2/100,000 population per year. Aims and Objectives: The aims
Externí odkaz:
https://doaj.org/article/66a2c9f2e83e4455b3c92ae68ce35546